A single amino acid variation within an immunodominant AKR/Gross MuLV cytotoxic T-lymphocyte epitope leads to a loss in immunogenicity

Viral Immunology

Volumn 11, Issue 4, 1998, Pages 197-213

  Kim, Victor ^a   Green, William R ^a  

^a NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISSOCIATION; ENDOPLASMIC RETICULUM; FRIEND LEUKEMIA VIRUS; IMMUNOGENICITY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; RAUSCHER LEUKEMIA VIRUS; SEQUENCE HOMOLOGY; SINDBIS VIRUS; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS RECOMBINANT;

EID: 0032430041     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.197     Document Type: Article

References (70)

1. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489-492.
2. Anton, L.C., J.W. Yewdell, and J.R. Bennink. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158:2535-2542.
3. Arfin, S.M., R.L. Kendall, L. Hall, L.H. Weaver, A.E. Stewart, B.W. Matthews, and R.A. Bradshaw. 1995. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc. Natl. Acad. Sci. USA 92:7714-7718.
4. Bacik, I., J.H. Cox, R. Anderson, J.W. Yewdell, and J.R. Bennink. 1994. TAP (Transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide. J. Immunol.152:381-387.
5. Brodsky, J.L., and A.A. McCracken. 1997. ER-associated and proteasome-mediated protein degredation: how two topologically restricted events came together. Trends Cell Biol. 7:151-156.
6. Burg, S.H., M.J.W. Visseren, R.M.P. Brandt, W.M. Kast, and C.J.M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308-3314.
7. Chattopadhyay, S.K., M.R. Lander, S. Gupta, E. Rands, and D.R. Lowy. 1981. Origin of mink cytopathic focus-forming (MCF) viruses: comparison with ecotropic and xenotropic murine leukemia virus genomes. Virology 113:465-483.
8. Chen, W., S. Khilko, J. Fecondo, D.H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatiblity complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471-1483.
9. Cloyd, M.W., J.W. Hartley, and W.P. Rowe. 1980. Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses. J. Exp. Med. 151:542-552.
10. Cloyd, M.W., M.M. Thompson, and J.W. Hartley. 1985. Host range of mink cell focus-inducing viruses. Virology 140:239-248.
11. Coffin, J.M. 1982. Endogenous retroviruses. In Weiss, R., N. Teich, H.E. Varmus, and J.M. Coffin, (eds.): RNA Tumor Viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; pp. 1109-1203.
12. Coffin, J.M. 1992. Structure and classification of retroviruses. In Levy, J., (ed.): The Retroviridae. Plenum Press, New York; pp. 19-49.
13. b mice. Virology. 202:500-505.
14. Coppola, M.A., T.M. Lam, R.R. Strawbridge, and W.R. Green. 1995. Recognition of endogenous ecotropic murine leukemia viruses by anti-AKR/Gross virus cytotoxic T lymphocytes (CTL): Epitope variation in a CTL-resistant virus. J. Gen. Virol. 76:635-641.
15. Elder, J.H., J.W. Gautsch, F.C. Jensen, R.A. Lerner, J.W. Hartley, and W.P. Rowe. 1977. Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc. Natl. Acad. Sci. USA 74:4676-4680.
16. Elliott, T. 1997. How does TAP associate with MHC class I molecules? Immunol. Today 18:375-379.
17. Elliott, T. 1997. Transporter associated with antigen processing. Adv. Immunol. 65:47-109.
18. Fan, H. 1992. Retroviruses and their role in cancer. In Levy, J., (ed.): The Retroviridae. Plenum Press, New York; pp. 313-362.
19. Feltkamp, M.C.W., M.P.M. Vierboom, R.E.M. Toes, F. Ossendorp, J. Schegget, C.J.M. Melief, and W.M. Kast. 1995. Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization. Immunol. Lett. 47:1-8.
20. Feltkamp, M.C.W., M.P.M. Vierboom, W.M. Kast, and C.J.M. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 31:1391-1401.
21. Ferris, R.L., C. Buck, S.A. Hammond, A.S. Woods, R.J. Cotter, M. Takiguchi, Y. Igarashi, Y. Ichikawa, and R.F. Siliciano. 1996. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. J. Immunol. 156:834-840.
22. b. 257:919-926.
23. Fu, T.M., L.M. Mylin, T.D. Schell, I. Bacik, G. Russ, J.W. Yewdell, J.R. Bennink, and S.S. Tevethia. 1988. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J. Virol. 72:1469-1481.
24. Garcia, K.C., M. Degano, R.L. Stanfield, A. Brunmark, M.R. Jackson, P.A. Peterson, L. Teyton, and I.A. Wilson. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TcR-MHC complex. Science 274:209-219.
25. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287-299.
26. Goldberg, A.L., and K.L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357:375-379.
27. Green, W.R. 1980. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the Gross cell surface antigen. J. Immunol. 125:2584-2590.
28. Green, W.R. 1984. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. J. Immunol. 132:2658-2664.
29. Green, W.R., and P.M. Smith. 1996. Endogenous ecotropic and recombinant MCF mouse retroviral variation and escape from antiviral CTL. Sem. Virol. 7:49-60.
30. Green, W.R., R.C. Nowinski, and C.S. Henney. 1979. The generation and specificity of cytotoxic T cells raised against syneneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J. Exp. Med. 150:51-66.
31. + T cells. Nature 364:158-161.
32. + CTL. J. Immunol. 154:6140-6156.
33. Hartley, J.W., N.K. Wolford, L.J. Old, and W.P. Rowe. 1977. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Natl. Acad. Sci. USA 74:789-792.
34. Heemels, M.T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463-491.
35. Hegde, R.S. and V.R. Lingappa. 1997. Membrane protein biogenesis: Regulated complexity at the endoplasmic reticulum. Cell. 91:575-582.
36. Hughes, E.A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896-1901.
37. Huppa, J.B. and H.L. Ploegh. 1997. The α-chain of the T cell antigen receptor is degraded in the cytosol. Immunity. 7:113-122.
38. Jameson, S.C. and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
39. Jenkins, N.A., N.G. Copeland, B.A. Taylor, and B.K. Lee. 1982. Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus. J. Virol. 43:26-36.
40. Karre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-678.
41. Khan, A.S. 1984. Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses. J. Virol. 50:864-871.
42. Koopmann, J.O., G.J. Hammerling, and F. Momburg. 1997. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9:80-88.
43. Kopito, R.R. 1997. ER quality control: The cytoplasmic connection. Cell. 88:427-430.
44. Kozak, C.A. and S. Ruscetti. 1992. Retroviruses in rodents. In Levy, J., (ed.): The Retroviridae. Plenum Press, New York; pp. 405-481.
45. Matsumura, M., D.H. Fremont, P.A. Peterson, and I.A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. 257:927-934.
46. Momburg, F., and G.J. Hammerling. 1998. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv. Immunol. 68:191-256.
47. Mosse, C.A., L. Meadows, C.J. Luckey, D.J. Kittlesen, E.L. Huczko, C.L. Slingluff, J. Shabanowitz, D.F. Hunt, and V.H. Engelhard. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37-48.
48. Neisig, A., J. Roelse, A.J.A.M. Sijts, F. Ossendorp, M.C.W. Feltkamp, W.M. Kast, C.J.M. Melief, and J.J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154:1273-1279.
49. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P.M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:115-124.
50. Pamer, E., and Cresswell, P. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-358.
51. Plata, F. and F. Lily. 1979. Viral specificity of H-2 restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. J. Exp. Med. 150:1174-1186.
52. Purcell, A.W., W. Chen, N.J. Ede, J.J. Gorman, J.V. Fecondo, D.C. Jackson, Y. Zhao, and J. McCluskey. 1998. Avoidance of self-reactivity results in skewed CTL responses to rare components of synthetic immunogens. J. Immunol. 160:1085-1090.
53. Rammensee, H.G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: First listing. Immunogenetics. 41:178-228.
54. Salter, R.D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB hybrid. EMBO J. 5:943-949.
55. Sijts, A.J.A.M., and E.G. Pamer. 1997. Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: A mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J. Exp. Med. 185:1403-1411.
56. Sijts, A.J.A.M., F. Ossendorp, E.A.M. Menegede, P.J.V.D.E. Elsen, and C.J.M. Melief. 1994. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J. Immunol. 152:106-116.
57. Siliciano, R.F., and M.J. Soloski. 1995. MHC class I-restricted processing of transmembrane proteins. J. Immunol. 155:2-5.
58. Snyder, H.L., J.W. Yewdell, and J.R. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389-2394.
59. Stoye, J.P., and J.M. Coffin. 1987. The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J. Virol. 61:2659-2669.
60. Stoye, J.P., and J.M. Coffin. 1988. Polymorphism of murine endogenous proviruses revealed by using virus class-specific oligonucleotide probes. J. Virol. 62:168-175.
61. Stoye, J.P., C. Moroni, and J.M. Coffin. 1991. Virological events leading to spontaneous AKR thymomas. J. Virol. 65:1273-1285.
62. b molecule. Immunity 3:573-582.
63. Tobery, T.W., and R.F. Siliciano. 1997. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185:909-920.
64. b-restricted ovalbumin peptide suggests that the β-chain subunit can dominate the determination of peptide side chain specificity. J. Immunol. 159:2312-2317.
65. b-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J. Virol. 68:897-904.
66. White, H.D., M.D. Robbins, and W.R. Green. 1990. Mechanism of escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR/Gross virus cytolytic T lymphocytes. J. Virol. 64:2608-2619.
67. Wiertz, E.J.H.J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones, T.A. Rapoport, and H.L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432-438.
68. Yang, M., S. Omura, J.S. Bonifacino, and A.M. Weissman. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: Importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187:835-846.
69. Yewdell, J.W., L.C. Anton, and J.R. Bennink. 1996. Defective ribosomal products (DriPs). J. Immunol. 157:1823-1826.
70. York, I.A., and K.L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-396.